Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
Findings independent of socioeconomic characteristics, onset age, and other related disorders (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 15, 2021 Category: Psychiatry Tags: Dermatology, Family Medicine, Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
THURSDAY, April 15, 2021 -- Worse atopic dermatitis (AD) severity is associated with increased odds of learning disorders in pediatric patients, according to a study published online April 14 in JAMA Dermatology. Joy Wan, M.D., from the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2021 Category: Pharmaceuticals Source Type: news

Drug giant Eli Lilly bought an emerging Peninsula skin drug company last year — here's what's left of it
A blockbuster atopic dermatitis drug is moving closer to an FDA decision, another is rolling up into an Arizona company, another Bay Area company is launching, a Peninsula site is closing and 163 jobs are getting cut. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 12, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
NEW YORK--(BUSINESS WIRE) April 07, 2021 -- Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 7, 2021 Category: Drugs & Pharmacology Source Type: news

Contact Dermatitis Content Varies Among Social Media Sites Contact Dermatitis Content Varies Among Social Media Sites
Data on social media use suggest that approximately 65% of US adults regularly use social media, and 40% use it when making medical decisions.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 1, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Tralokinumab for Atopic Dermatitis: A Promising New Therapy Tralokinumab for Atopic Dermatitis: A Promising New Therapy
Multiple trials of tralokinumab, an interleukin-13 inhibitor, indicate that it is a promising treatment option for patients with moderate-to-severe atopic dermatitis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Self-inflicted dermatoses in adolescence: a case series - Sarti L, Fusco E, Oranges T, Nocentini S, Giovannini M, Liccioli G, Barni S, Martin R, Mori F, Filippeschi C.
We describe three teenagers referred to Meyer Children's University Hospital with unusual rashes. A 14‐year‐old girl (case 1) was referred to the Allergy Unit with suspected Stevens‐Johnso... (Source: SafetyLit)
Source: SafetyLit - March 29, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Itch Response Faster With Abrocitinib Compared to Dupilumab Itch Response Faster With Abrocitinib Compared to Dupilumab
An experimental oral Janus kinase 1 (JAK1) inhibitor, abrocitinib, showed greater itch reduction after 2 weeks of treatment than dupilumab in patients with moderate to severe atopic dermatitis, in a multicenter, randomized trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Abrocitinib Bests Placebo for Treatment of Atopic Dermatitis
WEDNESDAY, March 24, 2021 -- For moderate-to-severe atopic dermatitis, the oral Janus kinase 1 (JAK1) inhibitor abrocitinib at 200 mg or 100 mg once daily results in significantly greater reductions in signs and symptoms versus placebo, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2021 Category: Pharmaceuticals Source Type: news

Highlights in Atopic Dermatitis From AAAAI 2021 Highlights in Atopic Dermatitis From AAAAI 2021
Dr Elaine Siegfried discusses highlights in atopic dermatitis from AAAAI 2021: the efficacy of abrocitinib, the impact of COVID-19 on outcomes, and the challenges around food allergy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news

NIH study of early predictors, mechanisms of food allergy and eczema has begun
(NIH/National Institute of Allergy and Infectious Diseases) A study to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions, has begun. The observational study of children from birth to age 3 years will examine the origins of allergic disease by integrating interdisciplinary analyses of data from more than 260 biological and environmental samples and survey responses from each of 2,500 families. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2021 Category: International Medicine & Public Health Source Type: news

Bacteriotherapy Passes Early Test in Atopic Dermatitis Study Bacteriotherapy Passes Early Test in Atopic Dermatitis Study
"And perhaps most exciting," Gallo added, is the finding that the subset of patients with AD who were most responsive to the ShA9 compound...showed improvement in...scores used to assess inflammation.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 11, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Soap substitute kills Covid just as well as alcohol sanitiser, study shows
Research, not yet peer-reviewed, shows antimicrobial lotion Dermol 500 neutralises virusCoronavirus – latest updatesSee all our coronavirus coverageIt ’s good news for chapped hands: an antimicrobial soap substitute commonly used by people with dry and itchy skin conditions has been shown to kill coronavirus.Since the start of the pandemic, people with no history of eczema or dermatitis have been developing sore and cracked skin as a result of increased hand-washing or using alcohol sanitiser gel.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 10, 2021 Category: Science Authors: Linda Geddes Tags: Medical research Coronavirus Society Science Health UK news Microbiology Source Type: news

Molecular mechanisms identified in chronic skin inflammation
(Medical University of Vienna) Frequently occurring chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis have different causes. A team at MedUni Vienna has now been able to identify new molecular mechanisms as causes that could provide suitable starting points for new therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2021 Category: International Medicine & Public Health Source Type: news

Severe Atopic Dermatitis Often Puts a Dent in Quality of Life Severe Atopic Dermatitis Often Puts a Dent in Quality of Life
In his role as head of the division of pediatric behavioral health at National Jewish Health, Bruce Bender, PhD, helps kids and adults navigate the adverse effects of severe AD on their quality of life.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 5, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Novel Oral Agent Effective in Teens With Atopic Dermatitis Novel Oral Agent Effective in Teens With Atopic Dermatitis
The investigational drug abrocitinib, shown in a recent phase 3 trial to be effective for moderate to severe atopic dermatitis in adults 18 years and older, is also safe and effective in teens.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 3, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis
Review current evidence for the use of crisaborole 2% ointment, a topical phosphodiesterase-4 inhibitor, for the treatment of atopic dermatitis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 2, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Last-itch effort: Fighting the bacteria that exacerbate eczema with bacteria
(University of California - San Diego) Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2021 Category: International Medicine & Public Health Source Type: news

Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis
WILMINGTON, Del.--(BUSINESS WIRE) February 19, 2021 -- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ruxolitinib cream, a selective JAK1/JAK2... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - February 19, 2021 Category: Drugs & Pharmacology Source Type: news

Atopic Dermatitis vs Psoriasis
Title: Atopic Dermatitis vs PsoriasisCategory: Diseases and ConditionsCreated: 2/11/2021 12:00:00 AMLast Editorial Review: 2/11/2021 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - February 11, 2021 Category: Dermatology Source Type: news

Constants of atopic dermatitis recurrence
(Source: ScienceNOW)
Source: ScienceNOW - January 28, 2021 Category: Science Authors: Erkes, D. A. Tags: twis Source Type: news

Developmental cell programs are co-opted in inflammatory skin disease
The skin confers biophysical and immunological protection through a complex cellular network established early in embryonic development. We profiled the transcriptomes of more than 500,000 single cells from developing human fetal skin, healthy adult skin, and adult skin with atopic dermatitis and psoriasis. We leveraged these datasets to compare cell states across development, homeostasis, and disease. Our analysis revealed an enrichment of innate immune cells in skin during the first trimester and clonal expansion of disease-associated lymphocytes in atopic dermatitis and psoriasis. We uncovered and validated in situ a re...
Source: ScienceNOW - January 21, 2021 Category: Science Authors: Reynolds, G., Vegh, P., Fletcher, J., Poyner, E. F. M., Stephenson, E., Goh, I., Botting, R. A., Huang, N., Olabi, B., Dubois, A., Dixon, D., Green, K., Maunder, D., Engelbert, J., Efremova, M., Polanski, K., Jardine, L., Jones, C., Ness, T., Horsfall, D. Tags: Genetics, Immunology, Online Only r-articles Source Type: news

Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study. " Clinical and experimental dermatology 46(1): 142-144
COVID-19 healthcare workers (HCWs) require frequent handwashing and use of personal protective equipment (PPE) to prevent infection. However, evidence is emerging that these practices are causing adverse effects on their skin integrity. A single-centre, cross-sectional study of HCWs from an Irish hospital was undertaken to evaluate the degree of COVID-19-related irritant contact dermatitis (ICD) between April and May 2020. Of 270 participants surveyed, 223 (82.6%) reported symptoms of ICD. The hands were the most commonly affected site (76.47%) and the most frequently reported symptom was dry skin (75.37%). Nearly all (268...
Source: Current Awareness Service for Health (CASH) - January 15, 2021 Category: Consumer Health News Source Type: news

Baseline Body Surface Area May Drive Optimal Baricitinib Response Baseline Body Surface Area May Drive Optimal Baricitinib Response
Patients with moderate to severe atopic dermatitis affecting between 10% and 50% of their body surface area account for the majority of those responders to baricitinib 2 mg.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Broadening participation in clinical trials: A win for all
The objective is to engage in rea l-world, evidence-based research and bring trials to the local community, where a significant proportion of cancer care is rendered,” he adds.   To help, Cardinal Health ’s real-world evidence and insights teams analyze the real-world data collected from the sites, which can be compared to results from clinical trials to demonstrate the real-world value of therapies.   By bringing these studies to the community, many of the usual challenges are overcome, adds Gajra. These include trial site location (typically academic institutions) and the distances that ...
Source: EyeForPharma - January 6, 2021 Category: Pharmaceuticals Authors: Joseph Constance Source Type: news

Gene Expression Different in Allergic, Irritant Contact Dermatitis Gene Expression Different in Allergic, Irritant Contact Dermatitis
Artificial intelligence (AI) can help identify biomarkers to distinguish between contact dermatitis (CD) due to allergic reactions or to irritants, according to new findings.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

When marriage hurts: a literature review of embedded jewellery ring injuries - Tak S, Irvine E, Baba M, Ghanate V, Khairandish H.
A ring is traditionally worn as a symbol of love and affection or as decorative ornamental jewellery. However, rings are not without risk. The spectrum of danger can range from debilitating avulsion injuries to simple contact dermatitis. Unknown to many,... (Source: SafetyLit)
Source: SafetyLit - January 1, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Atopic Dermatitis Tied to Autoimmune Diseases
MONDAY, Dec. 21, 2020 -- Autoimmune disease comorbidity among adults with atopic dermatitis is common, according to a study recently published the British Journal of Dermatology. Lina U. Ivert, from the Karolinska Institutet in Stockholm, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 21, 2020 Category: Pharmaceuticals Source Type: news

Antihistamine Prescribing for AD Varies by Specialty Antihistamine Prescribing for AD Varies by Specialty
Dermatologists are more likely than are nondermatologists to follow practice guidelines when prescribing antihistamines to treat pruritus associated with atopic dermatitis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 15, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Study identifies links between atopic dermatitis and autoimmune diseases
(Wiley) In a recent study published in the British Journal of Dermatology, individuals with atopic dermatitis, or eczema, were more likely to also have various autoimmune diseases, especially those involving the skin, the gastrointestinal tract, or the connective tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2020 Category: International Medicine & Public Health Source Type: news

What are Potential Problems Associated with Helicobacter pylori?
Discussion Helicobacter pylori (H. pylori) is a microaerophilis, spiral bacterium that is a prevalent human pathogen. How this infection affects individuals is different in adults and children. Overall seroprevalence rate in children world-wide was estimated to be ~33%, but this seroprevalence rate is decreasing in the developed world for both adults and children. It is acquired in childhood and can persist through colonization throughout life if untreated. Fortunately, it often is asymptomatic and generally does not cause serious disease in children. Some serotyping data shows that within families children acquire it more...
Source: PediatricEducation.org - November 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Eczema: Eight tips to help ease inflammation and discomfort caused by the skin condition
ECZEMA is an umbrella term to describe various sensitive skin disorders. Examples include atopic dermatitis, dyshidrotic eczema, and asteatotic eczema. Whichever type you have, these tips could help ease the discomfort. (Source: Daily Express - Health)
Source: Daily Express - Health - November 18, 2020 Category: Consumer Health News Source Type: news

Eczema More Common Among Black, Hispanic Kids
FRIDAY, Nov. 13, 2020 -- Black and Hispanic children in the United States have much higher rates of the skin condition eczema than white children, experts say. These disparities in eczema -- also called atopic dermatitis (AD) -- will be presented... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 13, 2020 Category: General Medicine Source Type: news

Fire coral dermatitis - Xu D, Coghill J, Burrows NP.
A 7-year-old, Caucasian female was snorkelling in the Sulu sea around Borneo, when her right anterior thigh made contact with fire coral (Millepora spp). She described a sharp sting and an excruciatingly painful urticarial rash subsequently developed (figu... (Source: SafetyLit)
Source: SafetyLit - November 11, 2020 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Abrocitinib Highly Effective as Long-term Monotherapy in AD Abrocitinib Highly Effective as Long-term Monotherapy in AD
The head-turning outcomes achieved at the higher studied dose of 200 mg once daily as monotherapy herald a new era in the management of atopic dermatitis.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 10, 2020 Category: Internal Medicine Tags: Dermatology News Source Type: news

Vitamin D Supplementation May Aid Severe Dermatitis
FRIDAY, Nov. 6, 2020 -- Vitamin D supplementation may aid clinical outcomes for pediatric patients with severe atopic dermatitis, according to a study published online Nov. 3 in Pharmacology Research& Perspectives. Noha O. Mansour, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 6, 2020 Category: Pharmaceuticals Source Type: news

' Soak-and-Smear' AD Protocol Backed by Evidence'Soak-and-Smear' AD Protocol Backed by Evidence
The most effective initial step for clearing atopic dermatitis in infants and young children involves daily bathing, followed by immediate application of a moisturizer, topical steroid, or both.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 5, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Vitamin D lessens symptoms of severe eczema in children
(Wiley) Vitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research& Perspectives. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 4, 2020 Category: International Medicine & Public Health Source Type: news

Atopic Dermatitis: Upadacitinib Effective in Two Phase 3 Trials Atopic Dermatitis: Upadacitinib Effective in Two Phase 3 Trials
The JAK inhibitor, currently approved for rheumatoid arthritis, yielded improvements in skin clearance, itch, and quality of life for nearly 1700 patients with moderate to severe disease.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 3, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity
Signs and symptoms of moderate to severe atopic dermatitis were significantly reduced with baricitinib 4 mg on top of topical corticosteroids, compared with placebo in the phase 3, BREEZE-AD7 study.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - October 26, 2020 Category: Dermatology Tags: Dermatology News Source Type: news

Taking the itch out of cancer immunotherapy
(University of Tsukuba) Researchers from the University of Tsukuba have determined that PD-1 expression on CD8 T cells is the biological pathway that leads to psoriasis-like dermatitis, an unfavorable side effect of cancer immunotherapy with PD-1 inhibitors. This finding offers hope that blocking this pathway can prevent or reduce the undesirable side effect and help cancer patients continue their treatment with improved quality-of-life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 26, 2020 Category: Cancer & Oncology Source Type: news

Dermatitis Herpetiformis May Be Common in Patients With Celiac Disease Dermatitis Herpetiformis May Be Common in Patients With Celiac Disease
As many as 8% of patients with celiac disease (CD) may also have dermatitis herpetiformis (DH), and these patients are less likely to receive counseling on gluten-free diets, suggests an online survey.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 21, 2020 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

What Are the Symptoms of Herpes Simplex Keratitis?
Discussion Herpes simplex virus (HSV) infections are common with an estimated 50% of the US population being infected by age 30, and with latent infection harboring in the trigeminal nerve in 100% of people by age 60 years. HSV infections can cause a vesicular or pustular skin rash that is painful, burning or pruritic and also flu-like symptoms with fever, chills, headache, and fatigue. HSV can also be asymptomatic. To laymen, herpes simplex viruses cause “cold sores,” but to health care personnel, herpes causes many systemic infections including eczema herpeticum, folliculitis, herpes gladiatorum, whitlow, e...
Source: PediatricEducation.org - October 5, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Dermatologists' perceptions of suicidality in dermatological practice: a survey of prevalence estimates and attitudes in Austria - Pronizius E, Voracek M.
BACKGROUND: Chronic illnesses belong to suicide risk factors. The goal of the current study was to estimate the rate of suicide-related behaviors in patients with atopic dermatitis, psoriasis, or acne from a third-person perspective (namely, Austrian derma... (Source: SafetyLit)
Source: SafetyLit - October 3, 2020 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Hand hygiene and caring for your hands has never been so important
Washing your hands is an effective way to help reduce the spread of coronavirus, protecting yourself and your patients. However, frequent hand washing can lead to and exacerbate dry skin issues including contact dermatitis – a painful, debilitating condition which may require nursing staff to be moved out of clinical areas due to the risk of infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 23, 2020 Category: Consumer Health News Source Type: news

EMA Panel Backs Baricitinib for Moderate-to-Severe Atopic Dermatitis EMA Panel Backs Baricitinib for Moderate-to-Severe Atopic Dermatitis
Baricitinib (Olumiant) would be the first JAK inhibitor (and oral medicine) indicated for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.International Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 23, 2020 Category: Allergy & Immunology Tags: Dermatology News Alert Source Type: news

CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis
Positive Opinion is the First Regulatory Action for Baricitinib as an Atopic Dermatitis Medicine INDIANAPOLIS, Sept. 18, 2020 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:INCY) announced today that th... Biopharmaceuticals, Dermatology, Regulatory Eli Lilly, Incyte , baricitinib, OLUMIANT, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2020 Category: Pharmaceuticals Source Type: news

Outbreak investigation of acid fly attack among residential students in a tertiary care centre in South India - Ramakrishnan D, George LS, Jacob A, Lais H, Rajeev M, Panicker KN, Marwaha V.
Paederus dermatitis is the skin irritation resulting from contact with the haemolymph of certain rove beetles, a group that is comprised by the genus Paederus. In May 2018, there was an increase in the number of residential students reporting with burning ... (Source: SafetyLit)
Source: SafetyLit - September 14, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

What is the Allergen Cross-Reactivity Rate of Legumes?
Discussion There are 8 common foods which compromise 90% of food allergens with those being peanuts, soybeans, cow’s milk, eggs, fish, crustacean/shellfish, wheat and tree nuts. Some people believe that lupin (a legume) is 9th. Legumes belong to the Fabaceae family. They provide protein, fat, vitamins other essential nutrients and therefore are used in the human diet throughout the world. “[A]llergenicity due to consumption of legumes in decreasing order may be peanut, soybean, lentil, chickpea, pea, mung bean and red gram.” Other common legumes include alfalfa, clovers, beans, lupins, mesquite, carob...
Source: PediatricEducation.org - September 14, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Study finds babies born in fall at higher risk for allergic diseases
(MediaSource) Researchers at National Jewish Health have determined that many allergic conditions likely start with dry, cracked skin, which leads to a chain reaction of allergic diseases known as the atopic march. It begins in infancy with atopic dermatitis and leads to food allergies, asthma and hay fever. Their latest study in The Journal of Allergy and Clinical Immunology: In Practice reveals that the time of year a baby is born may be a risk factor. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 9, 2020 Category: International Medicine & Public Health Source Type: news